Elucidating the roles of TNF-α and MCP-4 in MDD will not only advance our understanding of the underlying mechanisms but also present opportunities for developing targeted interventions that address the immunological dimension of the disorder. This evidence concerns the gene CCL13 and major depressive disorder.